Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis (Q34099068)

31 July 2017

0 references

1 reference

title

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis (English)

1 reference

polycystic ovary syndrome

31 July 2017

0 references

0 references

0 references

1 reference

1 reference

1 reference

1 reference

4

Robert J Norman

1 reference

31 July 2017

Lisa J Moran

1

1 reference

31 July 2017

Marie L Misso

series ordinal

2

1 reference

31 July 2017

Robert A Wild

series ordinal

3

1 reference

31 July 2017

16 February 2010

1 reference

Human Reproduction Update

31 July 2017

1 reference

31 July 2017

16

1 reference

31 July 2017

347-363

1 reference

31 July 2017

4

1 reference

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

31 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Polycystic ovary syndrome and abnormalities in glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Selecting controls is not selecting "normals": design and analysis issues for studying the etiology of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

The metabolic syndrome in Australia: prevalence using four definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Platelet Dysfunction in Lean Women with Polycystic Ovary Syndrome and Association with Insulin Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Screening women with polycystic ovary syndrome for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Abdominal adiposity and the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Polycystic ovary syndrome and mental health: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Fasting serum insulin concentration and early insulin response as risk determinants for developing diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Vascular dysfunction and metabolic parameters in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Familial associations between polycystic ovarian syndrome and common diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Polymorphism of glycogen synthetase gene in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Insulin and risk of cardiovascular disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Insulin secretion in women who have polycystic ovary syndrome and carry the Gly972Arg variant of insulin receptor substrate-1 in response to a high-glycemic or low-glycemic carbohydrate load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

The management of insulin resistance in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Cardiovascular risk factors in young Czech females with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Metabolic syndrome in young Czech women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

Impact of obesity on the risk for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ001

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMQ001

1 reference

release_5j6uceuqznb45jowubq4dig2bi

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5j6uceuqznb45jowubq4dig2bi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference